CD163 and bladder transitional cell carcinoma: Additionally, our immunofluorescence results showed no significant differences in macrophage M1 (INOS) or M2 (Cd163) phenotype activation within CD276 cKO tumors (Supplementary Fig. 4g)., suggesting that CD276 is dispensable for TAMs polarization in BLCA.